INFLUENCE OF HYPERCORTISOLEMIA ON SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-II AND INTERLEUKIN-1 RECEPTOR ANTAGONIST RESPONSES TO ENDOTOXIN IN HUMAN-BEINGS

被引:46
|
作者
BARBER, AE
COYLE, SM
FISCHER, E
SMITH, C
VANDERPOLL, T
SHIRES, T
LOWRY, SF
机构
[1] SYNERGEN INC,BOULDER,CO 80301
[2] CORNELL UNIV,MED CTR,SURG METAB LAB,NEW YORK,NY 10021
关键词
D O I
10.1016/S0039-6060(05)80352-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. We have previously reported that the antecedent administration of glucocorticoids altered both the hormonal and proinflammatory cytokine responses to lipopolysaccharide (LPS) when administered to human volunteers. In that study, subjects with vastly exaggerated levels of tumor necrosis factor (TNF) and interleukin (IL)-6 12 and 144 hours after cortisol infusion exhibited hemodynamic and hormonal responses no different from those of untreated subjects after endotoxin. The current study examined levels of the antiinflammatory cytokines interleukin-1 receptor antagonist (IL-1ra) and soluble receptors to tumor necrosis factor (sTNF-R) in the same setting of the previous report. Methods. Hydrocortisone succinate was infused into healthy volunteers. LPS was then injected immediately or was delayed by 6, 12, or 144 hours (C, C-6, C-12, and C-144, respectively). Subjects receiving LPS alone served as controls. Plasma was analyzed to determine levels of TNF, sTNF-R and IL-1ra by enzyme-linked immunosorbent assay before administration of LPS and at 30-minute intervals after administration of LPS for 6 hours. Results. Levels of sTNF-R increased after PS administration in all groups (p < 0.05 versus baseline) with a significantly higher level recorded in the subjects having received hydrocortisone 144 hours before (C-144, p < 0.05 versus all other groups). TNF levels remained undetectable in association with immediate infusion of LPS (C) and the relatively short delay group (C6). This cytokine peaked 90 minutes after LPS in all other groups, with a significantly higher peak in the C-144 subjects when compared with controls. IL-1ra levels rose in all groups but to a lesser extent in the C group (p < 0.05). Conclusions. These data confirm that glucorticoids influence the production of both sTNF-R and IL-1ra. The potential for an exaggerated response of sTNF-R exists for an extended period of time after exposure to glucocorticoids.
引用
收藏
页码:406 / 411
页数:6
相关论文
共 50 条
  • [31] TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 AS MEDIATORS OF ENDOTOXIN-INDUCED BENEFICIAL-EFFECTS
    URBASCHEK, R
    URBASCHEK, B
    REVIEWS OF INFECTIOUS DISEASES, 1987, 9 : S607 - S615
  • [32] Interleukin-1,β interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides
    Alstergren, P
    Benavente, C
    Kopp, S
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 61 (10) : 1171 - 1178
  • [33] EXPRESSION, IN ESCHERICHIA-COLI, OF A SOLUBLE HUMAN TUMOR-NECROSIS-FACTOR RECEPTOR
    SACCARDO, MB
    GRAZIOLI, L
    COZZI, E
    SARMIENTOS, P
    MARCUCCI, F
    JOURNAL OF BIOTECHNOLOGY, 1993, 30 (03) : 367 - 378
  • [34] TUMOR-NECROSIS-FACTOR-ALPHA INDUCES INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST PRODUCTION BY CULTURED HUMAN KERATINOCYTES
    KUTSCH, CL
    NORRIS, DA
    AREND, WP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (01) : 79 - 85
  • [35] Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood
    Simon Rütten
    Gerald F. Schusser
    Getu Abraham
    Wieland Schrödl
    BMC Veterinary Research, 12
  • [36] Impact of interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy
    Shu, KH
    Lee, SH
    Cheng, CH
    Wu, MJ
    Lian, JD
    KIDNEY INTERNATIONAL, 2000, 58 (02) : 783 - 789
  • [37] Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood
    Ruetten, Simon
    Schusser, Gerald F.
    Abraham, Getu
    Schroedl, Wieland
    BMC VETERINARY RESEARCH, 2016, 12
  • [38] Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress
    Pomianek, MJ
    Colton, CK
    Dinarello, CA
    Miller, LC
    ASAIO JOURNAL, 1996, 42 (01) : 52 - 59
  • [39] Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain
    Sweitzer, S
    Martin, D
    Deleo, JA
    NEUROSCIENCE, 2001, 103 (02) : 529 - 539
  • [40] TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, AND INTERLEUKIN-6 IN NORMAL HUMAN-PREGNANCY
    OPSJON, SL
    WATHEN, NC
    TINGULSTAD, S
    WIEDSWANG, G
    SUNDAN, A
    WAAGE, A
    AUSTGULEN, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (02) : 397 - 404